BridgeBio Pharma, Inc. BBIO

Healthcare · Biotechnology · valued as of 2026-11-02 · statements 2025-12-31

Average Intrinsic Value
-$2.51B
Market Cap
$13.09B
Margin of Safety
—
Intrinsic / Market Ratio
-0.19

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

-2.51B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

-2.51B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

-2.51B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

-2.51B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

-2.51B USD

from the sum above

Market Cap

13.09B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

-0.19×

the ratio the screener ranks by; Margin of Safety — (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: -2.51B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).

The earnings power value was not computed (a NOPAT at or below zero this year), so the value is the book value today, -2.51B USD.

Market value

Market Cap13.09B USD

Today's price times the shares.

Value vs market

Margin of Safety—

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): -2.51B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.

The projection was not made (a profit at or below zero in the latest three years), so the value is the book value today, -2.51B USD, as the screener leaves it.

①Present Value of the 15 Years of FCFE

Not in the value

②Equity at Year 15, Today

Not in the value

Market value

Market Cap13.09B USD

Today's price times the shares.

Value vs market

Margin of Safety—

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): -2.51B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (an operating profit at or below zero in the latest three years), so the value is the book value today, -2.51B USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Debt Today

Not in the value

Market value

Market Cap13.09B USD

Today's price times the shares.

Value vs market

Margin of Safety—

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 9.53%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.97×Market Risk Premium 6.00%= 10.33%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC 25.00% (default): the statements print a tax provision of 435.43K USD on a pretax income of -733.24M USD, which gives no rate between 0 and the profit before tax, so the 25% default stands for the tax the interest saves.

Interest Expense =EBIT -554.82M USD−Pretax Income -733.24M USD= 178.42M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 178.42M USDTotal Debt 2.50B USD×(1 − Tax Rate for WACC 25.00%)= 5.36%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 2.50B USDMarket Cap + Total Debt 13.09B USD + 2.50B USD= 16.01%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 83.99%×Cost of Equity 10.33%+Debt Weight 16.01%×Cost of Debt 5.36%= 9.53%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 1.22B USD − Total Liabilities 3.73B USD = Book Value Today -2.51B USD

Total Debt 2.50B USD − Cash and Short-Term Investments 720.88M USD = Net Debt Today 1.78B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 111.5%at most 5%does not pass195,284,352 / 175,082,951
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets22.9%at least -10.0%passes(-446.36M USD − -725.66M USD) ÷ 1.22B USD
Price to bookMarket Cap ÷ Book Value Today—at most 3×not measured13.09B USD ÷ -2.51B USD
Operating marginOperating Income ÷ Revenue-100.0%above 10.0%does not pass-502.57M USD ÷ 502.58M USD
Revenue growthRevenue ÷ Revenue a Year Before − 1126.3%above 10.0%passes502.58M USD / 222.12M USD
Net cash(Cash − Total Debt) ÷ Market Cap-13.9%above -30%passes(678.59M USD − 2.50B USD) ÷ 13.09B USD
Operating efficiencyOperating Income ÷ Gross Profit-104.4%above 25.0%does not pass-502.57M USD ÷ 481.60M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

67 USD

Enterprise value

15.76B USD

market cap plus net debt

EV / EBITDA

-33.30×

Price / book

-5.19×

the provider's book

Price / earnings

—

Return on equity

—

the provider's, not the engine's

Profit margin

-97.0%

Revenue growth

120.4%

Analyst target, mean

109 USD

Analysts

21

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

77.73M9.31M222.12M502.58M

Gross profit

74.29M6.86M218.24M481.60M

Operating income

-468.91M-600.04M-577.95M-502.57M

EBITDA

operating income before depreciation and amortisation

-397.84M-566.03M-437.27M-549.38M

Pretax income

-485.14M-653.90M-542.74M-733.24M

Net income

-481.66M-643.85M-536.30M-725.66M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

-429.63M-635.91M-637.64M-693.99M

R&D

399.86M456.17M506.97M452.40M
Balance sheet, year end

Total assets

623.66M546.93M920.26M936.96M

Total liabilities

1.87B1.89B2.38B3.02B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

-1.26B-1.36B-1.47B-2.09B

Total debt

1.73B1.74B1.73B1.86B

Cash and equivalents

377.07M376.31M681.78M570.69M

Net PP&E

fixed assets after depreciation

25.27M19.86M12.79M13.53M

Working capital

current assets less current liabilities

427.85M334.08M566.86M510.29M
Cash flow

Operating cash flow

-419.91M-528.25M-521.25M-446.36M

Capital expenditure

paid out, so below zero

-6.33M-1.31M-8.92M-9.60M

Depreciation and amortisation

6.78M6.50M6.08M5.44M

Free cash flow

operating cash flow plus capital expenditure

-426.24M-529.56M-530.16M-455.96M